Moderna Inc (MRNA)
100.23
-3.30
(-3.19%)
USD |
NASDAQ |
Sep 21, 16:00
100.08
-0.15
(-0.15%)
After-Hours: 20:00
Moderna Enterprise Value: 29.69B for Sept. 21, 2023
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 21, 2023 | 29.69B |
| September 20, 2023 | 30.94B |
| September 19, 2023 | 32.17B |
| September 18, 2023 | 31.18B |
| September 15, 2023 | 35.15B |
| September 14, 2023 | 34.48B |
| September 13, 2023 | 32.87B |
| September 12, 2023 | 31.59B |
| September 11, 2023 | 31.81B |
| September 08, 2023 | 32.51B |
| September 07, 2023 | 32.78B |
| September 06, 2023 | 32.74B |
| September 05, 2023 | 33.16B |
| September 01, 2023 | 34.38B |
| August 31, 2023 | 34.57B |
| August 30, 2023 | 35.93B |
| August 29, 2023 | 35.69B |
| August 28, 2023 | 34.86B |
| August 25, 2023 | 34.14B |
| August 24, 2023 | 34.41B |
| August 23, 2023 | 35.48B |
| August 22, 2023 | 35.78B |
| August 21, 2023 | 33.82B |
| August 18, 2023 | 30.22B |
| August 17, 2023 | 31.98B |
| Date | Value |
|---|---|
| August 16, 2023 | 29.19B |
| August 15, 2023 | 28.23B |
| August 14, 2023 | 29.60B |
| August 11, 2023 | 30.17B |
| August 10, 2023 | 29.71B |
| August 09, 2023 | 30.29B |
| August 08, 2023 | 29.50B |
| August 07, 2023 | 30.06B |
| August 04, 2023 | 32.72B |
| August 03, 2023 | 33.39B |
| August 02, 2023 | 33.49B |
| August 01, 2023 | 34.91B |
| July 31, 2023 | 36.32B |
| July 28, 2023 | 36.75B |
| July 27, 2023 | 36.69B |
| July 26, 2023 | 37.51B |
| July 25, 2023 | 37.97B |
| July 24, 2023 | 38.41B |
| July 21, 2023 | 39.71B |
| July 20, 2023 | 39.08B |
| July 19, 2023 | 39.23B |
| July 18, 2023 | 38.26B |
| July 17, 2023 | 38.25B |
| July 14, 2023 | 37.78B |
| July 13, 2023 | 39.78B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
2.978B
Minimum
Aug 05 2019
187.56B
Maximum
Aug 09 2021
42.48B
Average
40.23B
Median
Enterprise Value Benchmarks
| Merck & Co Inc | 301.41B |
| Pfizer Inc | 206.30B |
| Eli Lilly and Co | 538.31B |
| Novavax Inc | 348.49M |
| Johnson & Johnson | 407.64B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.38B |
| Revenue (Quarterly) | 316.00M |
| Total Expenses (Quarterly) | 2.183B |
| EPS Diluted (Quarterly) | -3.62 |
| Gross Profit Margin (Quarterly) | -131.3% |
| Profit Margin (Quarterly) | -436.7% |
| Earnings Yield | 2.70% |
| Operating Earnings Yield | 1.28% |
| Normalized Earnings Yield | 2.723 |